Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

SkylineDx’s SKY92 test with fluorescence in situ hybridisation testing led to more accurate identification of high-risk ...

Study reveals multiple high-risk genetic changes predict worse multiple myeloma outcomes across all treatments.

The CHMP recommends conditional marketing authorization of REGN's linvoseltamab to treat adults with relapsed and refractory multiple myeloma.

In spite of recent advances in the management of multiple myeloma, cure has been elusive, with efforts to improve long-term outcomes thwarted by repeated cycles of relapse and remission. This is ...

Janet Figge donates painting to The University of Kansas Cancer Center at the St. Francis Campus to honor her late husband's ...

Zoledronic acid injection is indicated for the treatment of hypercalcemia of malignancy and for the treatment of multiple ...

STOBOCLO ® (denosumab-bmwo) and OSENVELT ® (denosumab-bmwo) are approved by FDA for all indications of reference products ...

The Clinical Trial Finder Now Matches Multiple Myeloma Patients to Eligible Clinical Trials Based on Their Medical Records ...

Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have ...

Equities research analysts at Brookline Capital Management issued their Q2 2025 EPS estimates for shares of C4 Therapeutics ...